Preferential neurotrophic activity of fibroblast growth factor-20 for dopaminergic neurons through fibroblast growth factor receptor-1c
about
A two-stage meta-analysis identifies several new loci for Parkinson's diseaseLack of evidence for a genetic association between FGF20 and Parkinson's disease in Finnish and Greek patientsThe involvement of microRNAs in neurodegenerative diseasesFunctional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancersHomodimerization Controls the Fibroblast Growth Factor 9 Subfamily's Receptor Binding and Heparan Sulfate-Dependent Diffusion in the Extracellular MatrixRole of microRNAs in the Regulation of α-Synuclein Expression: A Systematic ReviewGrowth factors and feeder cells promote differentiation of human embryonic stem cells into dopaminergic neurons: a novel role for fibroblast growth factor-20Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model.Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease.Genetic variation in FGF20 modulates hippocampal biologyResearch resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse.Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease.ES cell-derived renewable and functional midbrain dopaminergic progenitors.FGF/EGF signaling regulates the renewal of early nephron progenitors during embryonic development.Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synucleinThe FGF family: biology, pathophysiology and therapyAdvances with microRNAs in Parkinson's disease research.Physical-chemical principles underlying RTK activation, and their implications for human disease.MicroRNAs in neurodegenerative diseases and their therapeutic potential.Association between FGF20 rs12720208 gene polymorphism and Parkinson's disease: a meta-analysis.Current disease modifying approaches to treat Parkinson's disease.miRNAs as biomarkers of neurodegenerative disorders.The potential role of neuroinflammation and transcription factors in Parkinson diseaseRoles of FGF20 in dopaminergic neurons and Parkinson's disease.Fibroblast growth factor-20 increases the yield of midbrain dopaminergic neurons derived from human embryonic stem cells.TNF superfamily member APRIL enhances midbrain dopaminergic axon growth and contributes to the nigrostriatal projection in vivo.Fibroblast growth factor 2 regulates dopaminergic neuron development in vivo.Quantitative assessment of the association between fibroblast growth factor 20 rs1721100 C/G polymorphism and the risk of sporadic Parkinson's diseases: a meta-analysis.Fibroblast growth factor 20 is protective towards dopaminergic neurons in vivo in a paracrine manner.A new hypothesis for Parkinson's disease pathogenesis: GTPase-p38 MAPK signaling and autophagy as convergence points of etiology and genomics
P2860
Q21144948-03A767F1-4CB0-400E-8B06-49460C949859Q24810778-B9D10D59-B686-4700-BB5A-91B0CBE35F14Q26858788-45314EEE-9931-458F-BEBF-27FA517084F0Q26998955-0C93FBD0-61CE-4309-B66E-DC849C7E37B7Q27646372-49FB67F3-208E-4843-AD07-FB303804DB05Q28080047-38A76FC3-CFCA-4C7B-99FC-F87B446BBCF0Q28115686-762DAE3F-AC30-4240-B884-6A665DA81000Q33565361-BFA73304-21A0-4CD5-B902-51846E18F340Q33910249-93607B11-5E09-4E2F-9992-5681F1A7A9BEQ34018828-9D75789D-020B-4948-ABC5-433B6A1A251FQ34197301-D1A83652-0A4F-4060-A061-A66A17C54333Q35020888-2D5B31F9-49CE-4544-A781-18C247421395Q35034938-53F8BE19-D889-4C49-B0B5-A96FB915397BQ35534606-DB6E8DD1-DEE0-4C1A-B218-F90629E6C501Q36718966-A82791E2-E446-4BFC-843C-DCA8430E9B91Q36933339-7DD03319-9616-438E-BB0D-049DD03008D4Q37221070-C2D4F20D-8506-4D8E-8738-0B1CE5DACF4CQ37917164-8B7C379B-CA48-4CA9-B856-D6621939B7E6Q37946984-5205854A-3233-407E-B615-E81139A858ACQ38381823-2727B4E2-BFB7-4ECF-A0C7-08C268591CB1Q38652153-9333C9BC-F1F3-4FD4-BF01-87B37BE5324CQ39104808-D737677D-7815-4B9D-B80E-2E259BAEC040Q39342497-51566DF0-FAF7-4A8B-A893-782F777F2E8EQ41237490-419A6441-3662-4EE5-8931-59DF51875CE8Q42181315-795F516B-907F-4C54-821C-244B3B4B405DQ47138321-CA849E96-920F-4C95-9985-B6F4154500E0Q48547347-CF7D8911-86F8-4E7B-AE1A-FEEF2B41F56AQ53149543-0E996A2C-702F-4A2C-8F25-3E5EF3F90125Q53401190-20CADC58-C1E2-4782-979E-B7C5E7C3FDFEQ58803163-8134A0F0-F13C-4E73-AE87-1B1CACB74427
P2860
Preferential neurotrophic activity of fibroblast growth factor-20 for dopaminergic neurons through fibroblast growth factor receptor-1c
description
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im Mai 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/05/15)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/05/15)
@nl
наукова стаття, опублікована в травні 2003
@uk
مقالة علمية (نشرت في 15-5-2003)
@ar
name
Preferential neurotrophic acti ...... last growth factor receptor-1c
@ast
Preferential neurotrophic acti ...... last growth factor receptor-1c
@en
Preferential neurotrophic acti ...... last growth factor receptor-1c
@nl
type
label
Preferential neurotrophic acti ...... last growth factor receptor-1c
@ast
Preferential neurotrophic acti ...... last growth factor receptor-1c
@en
Preferential neurotrophic acti ...... last growth factor receptor-1c
@nl
prefLabel
Preferential neurotrophic acti ...... last growth factor receptor-1c
@ast
Preferential neurotrophic acti ...... last growth factor receptor-1c
@en
Preferential neurotrophic acti ...... last growth factor receptor-1c
@nl
P2093
P356
P1476
Preferential neurotrophic acti ...... last growth factor receptor-1c
@en
P2093
Ayumi Miyake
Morichika Konishi
Nobuyuki Itoh
Shigeki Ohmachi
Tadahisa Mikami
P304
P356
10.1002/JNR.10592
P577
2003-05-15T00:00:00Z